BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33974189)

  • 1. Metachronous carcinogenesis of superficial esophagus squamous cell carcinoma after endoscopic submucosal dissection: incidence and risk stratification during long-term observation.
    Ogasawara N; Kikuchi D; Inoshita N; Nakayama A; Kohno K; Ochiai Y; Hayasaka J; Suzuki Y; Dan N; Okamura T; Mitsunaga Y; Tanaka M; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S; Iizuka T
    Esophagus; 2021 Oct; 18(4):806-816. PubMed ID: 33974189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive risk evaluation for metachronous carcinogenesis after endoscopic submucosal dissection of superficial pharyngeal squamous cell carcinoma.
    Ogasawara N; Kikuchi D; Tanaka M; Ochiai Y; Okamura T; Hayasaka J; Suzuki Y; Mitsunaga Y; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S
    Esophagus; 2022 Jul; 19(3):460-468. PubMed ID: 35099639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in Taiwan.
    Hsu MH; Wang WL; Chen TH; Tai CM; Wang HP; Lee CT
    BMC Gastroenterol; 2021 Aug; 21(1):308. PubMed ID: 34344303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Uno K; Koike T; Kusaka G; Takahashi Y; Ara N; Shimosegawa T
    Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Kagemoto K; Urabe Y; Miwata T; Oka S; Ochi H; Kitadai Y; Tanaka S; Chayama K
    Cancer Med; 2016 Jul; 5(7):1397-404. PubMed ID: 27038040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Kim GH; Min YW; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
    PLoS One; 2020; 15(9):e0238113. PubMed ID: 32886924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the aldehyde breath test for predicting metachronous recurrence in patients with esophageal squamous cell carcinoma and hypopharyngeal squamous cell carcinoma.
    Sasaki F; Mawatari S; Oda K; Yano H; Maeda H; Tanaka A; Arima S; Kumagai K; Tanoue S; Hashimoto S; Kanmura S; Ido A
    Esophagus; 2023 Oct; 20(4):749-756. PubMed ID: 37552454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage endoscopic resection for cT1N0M0 local recurrence after chemoradiotherapy for esophageal squamous cell carcinoma: endoscopic submucosal dissection versus endoscopic mucosal resection.
    Nakajo K; Yoda Y; Yamashita H; Takashima K; Murano T; Kadota T; Shinmura K; Ikematsu H; Akimoto T; Yano T
    Jpn J Clin Oncol; 2022 Sep; 52(9):982-991. PubMed ID: 35675653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
    Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
    Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
    Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar survival after endoscopic submucosal dissection and esophagectomy in early esophageal cancer and synchronous or metachronous head and neck cancer.
    Ke RT; Hsiao YH; Tai WC; Li SH; Yao CC; Chuang KH; Lai HH; Chen Y; Chen LC; Lu HI; Chen YH; Lo CM
    J Cardiothorac Surg; 2024 Feb; 19(1):52. PubMed ID: 38311758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blue laser imaging identifies endoscopic findings corresponding to metachronous esophageal squamous cell carcinoma.
    Azuma Y; Dohi O; Naito Y; Yasuda T; Yoshida T; Ishida T; Kitae H; Matsumura S; Doi T; Hirose R; Inoue K; Yoshida N; Kamada K; Uchiyama K; Takagi T; Ishikawa T; Konishi H; Nishimura A; Kishimoto M; Itoh Y
    Esophagus; 2022 Apr; 19(2):278-286. PubMed ID: 34773554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in elderly patients: a single-center retrospective cohort study.
    Ishido K; Tanabe S; Katada C; Kubota Y; Furue Y; Wada T; Watanabe A; Koizumi W
    Jpn J Clin Oncol; 2021 May; 51(6):895-904. PubMed ID: 33738500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of endoscopic submucosal dissection in patients who develop metachronous superficial esophageal squamous cell carcinoma close to a post-endoscopic submucosal dissection scar.
    Fukuhara M; Urabe Y; Oka S; Mizuno J; Tanaka H; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Arihiro K; Tanaka S
    Esophagus; 2023 Jan; 20(1):124-133. PubMed ID: 35917040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma.
    Suzuki Y; Kikuchi D; Hoteya S; Okamura T; Ochiai Y; Hayasaka J; Dan N; Mitsunaga Y; Tanaka M; Odagiri H; Nomura K; Yamashita S; Matsui A; Iizuka T
    Digestion; 2021; 102(4):622-629. PubMed ID: 32992320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.
    Katada C; Yokoyama T; Yano T; Kaneko K; Oda I; Shimizu Y; Doyama H; Koike T; Takizawa K; Hirao M; Okada H; Yoshii T; Konishi K; Yamanouchi T; Tsuda T; Omori T; Kobayashi N; Shimoda T; Ochiai A; Amanuma Y; Ohashi S; Matsuda T; Ishikawa H; Yokoyama A; Muto M
    Gastroenterology; 2016 Nov; 151(5):860-869.e7. PubMed ID: 27492616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
    Urabe Y; Kagemoto K; Nakamura K; Mizumoto T; Sanomura Y; Oka S; Ochi H; Tanaka S; Chayama K
    Esophagus; 2019 Apr; 16(2):141-146. PubMed ID: 30173282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell cancer in patients with prior gastrectomy.
    Xu JQ; Hu JW; Chen WF; Xu MD; Zhong YS; Chen SY; Zhang YQ; Ma LL; Qin WZ; Cai MY; Yao LQ; Zhou PH; Li QL
    Surg Endosc; 2021 May; 35(5):2229-2239. PubMed ID: 32430528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of endoscopic submucosal dissection for early oesophageal squamous cell neoplasia at a Western centre.
    Lorenzo D; Barret M; Leblanc S; Terris B; Beuvon F; Coriat R; Chaussade S; Prat F
    United European Gastroenterol J; 2019 Oct; 7(8):1084-1092. PubMed ID: 31662865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metachronous multiple esophageal squamous cell carcinomas and Lugol-voiding lesions after endoscopic mucosal resection.
    Urabe Y; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
    Endoscopy; 2009 Apr; 41(4):304-9. PubMed ID: 19340732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.